# HUMANIGEN, INC

HUMANIGEN, INC is a company headquartered in Short Hills, NJ, United States.

## Company overview

- **Legal name:** HUMANIGEN, INC
- **Former names in filing history:** KALOBIOS PHARMACEUTICALS INC (2004-06-04 to 2017-07-17)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Short Hills, NJ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001293310

## About

HUMANIGEN, INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001293310, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-30, it reported annual revenue of USD 2,514,000; net income of USD -70,730,000; total assets of USD 11,195,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $2.5M (USD 2,514,000)
- **Net income:** -$70.7M (USD -70,730,000)
- **Total assets:** $11.2M (USD 11,195,000)
- **Cash and equivalents:** $10.2M (USD 10,155,000)
- **Operating cash flow:** -$76.7M (USD -76,698,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $3.6M (USD 3,595,000)
- **Net income:** -$236.6M (USD -236,649,000)
- **Total assets:** $71.1M (USD 71,061,000)
- **Cash and equivalents:** $70.0M (USD 70,016,000)
- **Operating cash flow:** -$184.0M (USD -184,045,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $312,000 (USD 312,000)
- **Net income:** -$89.5M (USD -89,535,000)
- **Total assets:** $68.3M (USD 68,302,000)
- **Cash and equivalents:** $67.7M (USD 67,737,000)
- **Operating cash flow:** -$69.9M (USD -69,853,000)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2019 (period ended 2019-12-31)

- **Net income:** -$10.3M (USD -10,294,000)
- **Total assets:** $523,000 (USD 523,000)
- **Cash and equivalents:** $143,000 (USD 143,000)
- **Operating cash flow:** -$4.0M (USD -4,001,000)

## Recent SEC filings

- Form 8-K — filed 2024-01-08 — period 2024-01-03
- Form 8-K — filed 2023-09-14 — period 2023-09-08
- Form 8-K — filed 2023-07-25 — period 2023-07-18
- Form 10-Q — filed 2023-05-15 — period 2023-03-31
- Form 10-K/A — filed 2023-04-25 — period 2022-12-31 — AMENDMENT NO. 1
- Form 8-K — filed 2023-04-19 — period 2023-04-18
- Form 8-K — filed 2023-04-06 — period 2023-04-05
- Form 10-K — filed 2023-03-30 — period 2022-12-31
- Form 8-K — filed 2023-03-13 — period 2023-03-10
- Form 8-K — filed 2023-03-02 — period 2023-03-02
- Form 8-K — filed 2023-02-24 — period 2023-02-21
- Form 8-K — filed 2022-12-22 — period 2022-12-16

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/humanigen-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology